Sarissa Capital
alkermes argument to exclude candidacy because of his biogen directorship is now moot biogen announces changes to its board of directors | Sarissa Capital
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
22 of 41
Related slides by other companies
Alkermes
Investor Day
March 2021
evolution of alkermes strategy legacy strategy target evaluation driven by potential to add new medical value to established medications enabled rapid advancement to late stage development yielded advanced formulation science chemistry and drug delivery technologies applied to improve established pharmacology under review june | Alkermes
Other recent decks by Sarissa Capital
See all presentations (7 decks)
Activist
June 2023
Activist
June 2023
Activist
June 2023
Activist
February 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io